| Listed in Dosage. | ||||||||||||
Dosage | Adult: IV Increase yield of autologous blood As epoetin alfa or zeta: 600 u/kg twice wkly for 3 wk before surgery.IV/SC Anaemia of chronic renal failure As epoetin alfa: Predialysis and haemodialysis: Initial: 50 u/kg 3 times/wk; Peritoneal dialysis: 50 u/kg twice wkly. Anaemia in zidovudine-treated HIV-infected patients As epoetin alfa: Initial: 100 u/kg 3 times/wk for 8 wk. Max: 300 u/kg 3 times/wk. SC Anaemia related to non-myeloid malignant disease chemotherapy As epoetin alfa or zeta: Initial: 150 iu/kg 3 times/wk, up to 300 iu/kg 3 times/wk. Click to view erythropoietin Dosage by Indications | ||||||||||||
Contraindications | Uncontrolled hypertension, hypersensitivity to mammalian cell products and human albumin. | ||||||||||||
Special Precautions | Chronic renal failure, ischaemic heart diseases, hypertension, pregnancy, seizures, liver dysfunction, lactation. | ||||||||||||
Adverse Drug Reactions | Hypertension, myalgia, arthralgia, flu-like syndrome, rashes and urticaria. Potentially Fatal: Hypertensive crisis with encephalopathy-like symptoms e.g. headache, confusion, generalised seizures. Thrombosis. | ||||||||||||
Drug Interactions | Haematinics enhance efficiency. Increased dose of heparin in patients undergoing dialysis. Click to view more erythropoietin Drug Interactions | ||||||||||||
Pregnancy Category (US FDA) | |||||||||||||
Mechanism of Action | For details of the mechanism of action, pharmacology and pharmacokinetics and toxicology ... click to view erythropoietin | ||||||||||||
CIMS Class | Haematopoietic Agents | ||||||||||||
ATC Classification | B03XA01 - erythropoietin ; Belongs to the class of other antianemic preparations. |